24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
NeuroDerm
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:53
The breach that doesn’t have to happen - and what real cyber warfare looks like
13:42
"We are able to understand what drives cancer. This changes the entire course of the disease"
12:19
Why Disney is licensing AI instead of fighting it
11:53
Israeli healthtech faces a more selective funding market after the war
More stories
Buzz
Most popular
Daily
Weekly
1
Palo Alto Networks CEO: “We’re happy Wiz is now part of Google, it gives us more room to operate”
2
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
3
UAE reportedly behind Elbit’s record $2.3 billion defense deal
4
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
5
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
More news
NeuroDerm
3 stories about NeuroDerm
After a Two-Years Slump, Israeli Tech M&A, IPOs, Up 110%
27.12.17
|
Amarelle Wenkert
U.S. buyers accounted for the majority of deals in 2017, with as many as 33 deals valued at $4.1 billion, according to a new report
Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm
19.10.17
|
Lilach Baumer
NeuroDerm is looking to bring major change to Parkinson patients with its drug reformulation
Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion
25.07.17
|
Gil Kalian
Osaka-based Mitsubishi Tanabe said it expects the deal would help it achieve sales of over $700 million in the U.S. by 2020